berlition has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Chierici, S; Demeunynck, M; Dubois-Dauphin, M; Garin, D; Laferla, FM; Mahon, AB; Oukhatar, F; Sallanon, MM; Try, AC | 1 |
1 review(s) available for berlition and Amyloid Deposits
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
1 other study(ies) available for berlition and Amyloid Deposits
| Article | Year |
|---|---|
Proflavine derivatives as fluorescent imaging agents of amyloid deposits.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Fluorescent Dyes; Mice; Mice, Transgenic; Microscopy, Fluorescence; Peptide Fragments; Plaque, Amyloid; Proflavine | 2011 |